Trial intelligence / Profile preview

Donepezil Hippocampus Study in MCI

NCT00403520Phase 4Completed

Sponsor
Eisai Co., Ltd.
Start
Nov 2006
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Nov 2006; status: completed.

02

Drugs

donepezil
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT00403520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00403520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call